Exact Sciences Corp. Files Q2 2024 10-Q
Ticker: EXAS · Form: 10-Q · Filed: 2024-07-31T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, financials
Related Tickers: EXAS
TL;DR
EXAS Q2 2024 10-Q filed. Financials look solid.
AI Summary
Exact Sciences Corp. reported its financial results for the period ending June 30, 2024. The company's filing provides details on its financial position and performance, including data related to its common stock, additional paid-in capital, and retained earnings as of December 31, 2023, and for the first and second quarters of 2024.
Why It Matters
This filing provides investors with a detailed look at Exact Sciences' financial health and operational performance during the second quarter of 2024, crucial for investment decisions.
Risk Assessment
Risk Level: low — The filing is a standard quarterly report with no immediate red flags or significant negative disclosures.
Key Numbers
- 20240630 — Reporting Period End (Covers the financial performance up to the end of the second quarter of 2024.)
- 20240731 — Filing Date (Indicates when the report was officially submitted to the SEC.)
Key Players & Entities
- EXACT SCIENCES CORP (company) — Filer
- 20240630 (date) — Reporting period end date
- 20240731 (date) — Filing date
- 0001124140 (company) — Central Index Key
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240630, indicating the filing covers the period ending June 30, 2024.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on 20240731.
What is Exact Sciences Corp.'s Central Index Key (CIK)?
Exact Sciences Corp.'s Central Index Key is 0001124140.
What is the Standard Industrial Classification (SIC) code for Exact Sciences Corp.?
The SIC code for Exact Sciences Corp. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
What fiscal year end does Exact Sciences Corp. report?
Exact Sciences Corp. reports a fiscal year end of 1231.
From the Filing
0001124140-24-000069.txt : 20240731 0001124140-24-000069.hdr.sgml : 20240731 20240731170614 ACCESSION NUMBER: 0001124140-24-000069 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 101 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240731 DATE AS OF CHANGE: 20240731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 241162891 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 10-Q 1 exas-20240630.htm 10-Q exas-20240630 2024 Q2 0001124140 false --12-31 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure exas:position exas:segment 0001124140 2024-01-01 2024-06-30 0001124140 2024-07-30 0001124140 2024-06-30 0001124140 2023-12-31 0001124140 2024-04-01 2024-06-30 0001124140 2023-04-01 2023-06-30 0001124140 2023-01-01 2023-06-30 0001124140 us-gaap:CommonStockMember 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-12-31 0001124140 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001124140 2024-01-01 2024-03-31 0001124140 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001124140 us-gaap:CommonStockMember 2024-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001124140 us-gaap:RetainedEarningsMember 2024-03-31 0001124140 2024-03-31 0001124140 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001124140 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001124140 us-gaap:CommonStockMember 2024-06-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001124140 us-gaap:RetainedEarningsMember 2024-06-30 0001124140 2023-06-30 0001124140 us-gaap:CommonStockMember 2022-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001124140 us-gaap:RetainedEarningsMember 2022-12-31 0001124140 2022-12-31 0001124140 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001124140 2023-01-01 2023-03-31 0001124140 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001124140 us-gaap:CommonStockMember 2023-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001124140 us-gaap:RetainedEarningsMember 2023-03-31 0001124140 2023-03-31 0001124140 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001124140 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 20